Anorexia nervosa
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 15-65 at consent Diagnosis of anorexia nervosa per DSM-5-TR No change in psychotropic medication dose during the past 2 weeks Ability to provide written informed consent
Exclusion criteria
Exclusion criteria: Presence of physical or psychiatric conditions that preclude study procedures Insufficient Japanese proficiency to complete self-report questionnaires Deemed inappropriate for inclusion by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Global score on the Eating Disorder Examination Questionnaire (EDE-Q 6.0). | — |
Secondary
| Measure | Time frame |
|---|---|
| EDE-Q subscale score: Restraint EDE-Q subscale score: Eating Concern EDE-Q subscale score: Shape Concern EDE-Q subscale score: Weight Concern SCS score ACSo score PDQ-5 score Plasma/serum protein concentrations Expression levels of selected mRNAs Presence of MCT1 (T1470A) and MCT4 (C641T) polymorphisms Cytokine production of induced microglia-like cells (iMG). | — |
Countries
Japan
Contacts
Hokkaido University Hospital Department of Psychiatry and Neurology